Syra Health grants CEO 257,920 stock options

Both awards vest in 20% installments on each December 31 from 2026 through 2030; the options expire January 5, 2036.

This filing corrects an earlier one, and you can read the original Form 4 if you want to see what changed.

Rhea-AI Filing Summary

Syra Health Corp reported that its CEO, Gregory R. Alexander, received grants of 257,920 stock options and 110,537 restricted stock units on January 5, 2026. Twenty percent of each award vests on each December 31 from 2026 through 2030. The options have a $0.09 per-share exercise price and expire January 5, 2036.

Insider Trade Summary

Grant/Award: 368,457 shares

Grant/Award 2 txns

Insider Alexander Gregory R.

Role CEO

Type	Security	Shares	Price	Value
Grant/Award	Stock Options F2	257,920	$0.00	$0.00
Grant/Award	Restricted Stock Units F1	110,537	$0.00	$0.00

Holdings After Transaction: Stock Options — 257,920 contracts (Direct); Restricted Stock Units — 110,537 shares (Direct)

Footnotes (2)

1. F1. 20% of the RSUs vest on each of December 31, 2026, 2027, 2028, 2029 and 2030.
2. F2. 20% of the options vest on each of December 31, 2026, 2027, 2028, 2029 and 2030.

Key Figures

Stock options granted: 257,920 options Restricted stock units granted: 110,537 restricted stock units Option exercise price: $0.09 per share +2 more

5 metrics

Stock options granted 257,920 options Granted January 5, 2026

Restricted stock units granted 110,537 restricted stock units Granted January 5, 2026

Option exercise price $0.09 per share Stock options granted January 5, 2026

Vesting installment 20% Each December 31 from 2026 through 2030 for both awards

Option expiration date January 5, 2036 Stock options granted January 5, 2026

Key Terms

Restricted Stock Units, Stock Options, exercise price

3 terms

Restricted Stock Units financial

"20% of the RSUs vest on each of December 31"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Stock Options financial

"20% of the options vest on each of December 31"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

exercise price financial

"options vest on each of December 31"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many options and RSUs did SYRA's CEO receive?

CEO Gregory R. Alexander received grants of 257,920 stock options and 110,537 restricted stock units on January 5, 2026.

When do SYRA's stock options and RSUs vest?

Twenty percent of the RSUs vest on each of December 31, 2026, 2027, 2028, 2029 and 2030; the same schedule applies to 20% of the options.

What are the exercise price and expiration date for SYRA's options?

The options have a $0.09 per-share exercise price and expire on January 5, 2036.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/28/2026 - 04:36 PM Accepted by SEC EDGAR 09/28/2026 - 04:35 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Alexander Gregory R.

(Last) (First) (Middle)

C/O SYRA HEALTH CORP.

1119 KEYSTONE WAY N., #201

(Street)

CARMEL INDIANA 46032

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Syra Health Corp [ SYRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
01/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
02/03/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Restricted Stock Units	01/05/2026		A		110,537(1)	A	$0.00	110,537	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$0.09	01/05/2026		A		257,920		(2)	01/05/2036	Class A Common Stock	257,920	$0	257,920	D

Explanation of Responses:

1. 20% of the RSUs vest on each of December 31, 2026, 2027, 2028, 2029 and 2030.

2. 20% of the options vest on each of December 31, 2026, 2027, 2028, 2029 and 2030.

	/s/ Gregory Alexander	09/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)